Figure 3.
Potential serum biomarkers associated with severe CRS or neurotoxicity. A total of 10 serum biomarkers potentially associated with severe (A) CRS or (B) ICANS with significantly different levels in patients with mild (grade <3) vs severe (grade ≥3) toxicities are shown. ∗P > 1 × 10−2, P ≤ 5 × 10−2; ∗∗P > 1 × 10−3, P ≤ 1 × 10−2; ∗∗∗P > 1. × 10−4, P ≤ 1 × 10−3; ∗∗∗∗P ≤ 1 × 10−4.
